GZFL ameliorates CCl4-induced liver fibrosis in mouse in vivo by inhibiting TGF-β1/Smad2/3 signaling and activating IFN-γ/STAT1 signaling. This evidence concerns the gene SMAD2 and Hepatic fibrosis.